# Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT

> **NCT05592197** · NA · WITHDRAWN · sponsor: **Sun Yat-sen University**

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **DRUG:** Lenvatinib
- **PROCEDURE:** TACE
- **RADIATION:** External beam radiation (RT)

## Key facts

- **NCT ID:** NCT05592197
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-01
- **Primary completion:** 2023-03
- **Final completion:** 2023-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This is a sub-study of another one.
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05592197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05592197, "Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05592197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*